Geron Corporation (GERN) vs Verastem, Inc. (VSTM)
- Geron Corporation GERN 1.17 −4.88%
- Verastem, Inc. VSTM 8.65 −6.28%
Geron Corporation and Verastem, Inc. are both Biotechnology companies. Geron Corporation and Verastem, Inc. are of similar size ($835.9M and $790.2M). Verastem, Inc. grew revenue faster over the last twelve months: 472.9% against 24.4%. Geron Corporation has the higher net margin (−33.1% vs −231.6%) and the lower return on invested capital (−89.9% vs 0.00%). Across the 18 metrics below, Geron Corporation leads on 15 and Verastem, Inc. on 3.
Valuation
Profitability
| Metric | GERN | VSTM | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.51% | 86.35% | 65.16% |
| Operating margin | (25.31%) | (182.57%) | 0.00% |
| Net margin | (33.05%) | (231.59%) | 0.00% |
| Free cash flow margin | (56.10%) | (185.31%) | 0.00% |
| Return on equity | (28.28%) | (471.16%) | (56.36%) |
| Return on assets | (12.59%) | (100.65%) | (48.04%) |
| Return on invested capital | (89.85%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack